Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B

This study is currently recruiting participants.

Study NCT01271868 Information provided by Inspiration Biopharmaceuticals, Inc.

First Received: January 6, 2011 Last Updated: January 23, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)